Literature DB >> 26645578

N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.

Arpita Maity1, Biswadip Das1.   

Abstract

N6-methyladenosine (m(6) A) modification in mRNA is extremely widespread, and functionally modulates the eukaryotic transcriptome to influence mRNA splicing, export, localization, translation, and stability. Methylated adenines are present in a large subset of mRNAs and long noncoding RNAs (lncRNAs). Methylation is reversible, and this is accomplished by the orchestrated action of highly conserved methyltransferase (m(6) A writer) and demethylase (m(6) A eraser) enzymes to shape the cellular 'epitranscriptome'. The engraved 'methyl code' is subsequently decoded and executed by a group of m(6) A reader/effector components, which, in turn, govern the fate of the modified transcripts, thereby dictating their potential for translation. Reversible mRNA methylation thus adds another layer of regulation at the post-transcriptional level in the gene expression programme of eukaryotes that finely sculpts a highly dynamic proteome in order to respond to diverse cues during cellular differentiation, immune tolerance, and neuronal signalling.
© 2015 FEBS.

Entities:  

Keywords:  epitranscriptomics; m6A effector; m6A methylation; m6A reader; m6A writer; mRNA modification

Mesh:

Substances:

Year:  2015        PMID: 26645578     DOI: 10.1111/febs.13614

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  81 in total

Review 1.  RNA modifications as a common denominator between tRNA and mRNA.

Authors:  Ofri Levi; Yoav S Arava
Journal:  Curr Genet       Date:  2021-03-08       Impact factor: 3.886

Review 2.  The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers.

Authors:  Jinyan Wang; Lijuan Chen; Ping Qiang
Journal:  Cancer Cell Int       Date:  2021-02-10       Impact factor: 5.722

3.  YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells.

Authors:  Jixiang Chen; Yaocheng Sun; Xiao Xu; Dawei Wang; Junbo He; Hailang Zhou; Ying Lu; Jian Zeng; Fengyi Du; Aihua Gong; Min Xu
Journal:  Cell Cycle       Date:  2017-11-14       Impact factor: 4.534

4.  Deoxyribozyme-based method for absolute quantification of N 6-methyladenosine fractions at specific sites of RNA.

Authors:  Magda Bujnowska; Jiacheng Zhang; Qing Dai; Emily M Heideman; Jingyi Fei
Journal:  J Biol Chem       Date:  2020-04-08       Impact factor: 5.157

5.  Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m6A abrogation in RNA.

Authors:  Peihui Zhou; Ming Wu; Chaoyang Ye; Qingqing Xu; Li Wang
Journal:  J Biol Chem       Date:  2019-10-02       Impact factor: 5.157

6.  Chronic corticosterone exposure induces liver inflammation and fibrosis in association with m6A-linked post-transcriptional suppression of heat shock proteins in chicken.

Authors:  Yue Feng; Yun Hu; Zhen Hou; Qinwei Sun; Yimin Jia; Ruqian Zhao
Journal:  Cell Stress Chaperones       Date:  2019-11-19       Impact factor: 3.667

7.  The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-κB signaling.

Authors:  Jinjin Yu; Lujun Shen; Yanli Liu; Hong Ming; Xinxing Zhu; Maoping Chu; Juntang Lin
Journal:  Mol Cell Biochem       Date:  2019-10-23       Impact factor: 3.396

8.  N6-methyladenosine mediates arsenite-induced human keratinocyte transformation by suppressing p53 activation.

Authors:  Tianhe Zhao; Donglei Sun; Manyu Zhao; Yanhao Lai; Yuan Liu; Zunzhen Zhang
Journal:  Environ Pollut       Date:  2020-01-07       Impact factor: 8.071

Review 9.  Emerging Themes in Regulation of Global mRNA Turnover in cis.

Authors:  Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  Trends Biochem Sci       Date:  2016-09-16       Impact factor: 13.807

10.  Structures of the m(6)A Methyltransferase Complex: Two Subunits with Distinct but Coordinated Roles.

Authors:  Katherine I Zhou; Tao Pan
Journal:  Mol Cell       Date:  2016-07-21       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.